The History and Nosology of the Glycine Disorders: A Framework for Clinicians
- 12 January 2026
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 49 (1) , e70138
Abstract
Despite its simple chemical structure, glycine plays a complex role in the body. The glycine cleavage system regulates brain glycine levels and is a key one‐carbon donor to folate. Its metabolism is tightly integrated with that of serine. In addition to its biochemical role, glycine functions as a neurotransmitter and neuromodulator. Primary defects in the glycine cleavage system have long been known to cause human disease with a primarily neurological phenotype, and this was labelled as ‘nonketotic hyperglycinaemia’ in 1968. With increasing availability of molecular testing, many additional genetic conditions became apparent, as well as non‐genetic factors that cause hyperglycinaemia. There is now a much greater appreciation of the marked clinical impact of this heterogeneity. The previous terminology of ‘classical’ and ‘atypical’ nonketotic hyperglycinaemia does not adequately address these numerous genetic aetiologies, nor does it account for the phenotypic spectrum within individual genetic disorders. We provide here a clinically relevant classification of the glycine encephalopathies, based on the underlying genetic aetiology and its relation to the glycine cleavage system. Characteristic clinical and biochemical features of each condition, as well as non‐genetic phenocopies that cause hyperglycinaemia, are discussed in detail. This provides a readily usable framework for clinicians when faced with a patient with elevated glycine levels.Keywords
This publication has 183 references indexed in Scilit:
- Integrative Approach to Predict Severity in Nonketotic HyperglycinemiaAnnals of Neurology, 2022
- The Catalytic Mechanism of the Pyridoxal‐5′‐phosphate‐Dependent Enzyme, Histidine Decarboxylase: A Computational StudyChemistry – A European Journal, 2017
- Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemiaAnnals of Neurology, 2015
- Progressive vacuolating glycine leukoencephalopathy with pulmonary hypertensionAnnals of Neurology, 2006
- Comprehensive mutation analysis ofGLDC,AMT, andGCSHin nonketotic hyperglycinemiaHuman Mutation, 2006
- Persistent NKH with transient or absent symptoms and a homozygous GLDC mutationAnnals of Neurology, 2004
- Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutationsPrenatal Diagnosis, 1999
- Hyperglycinuria and Hyperglycinemia in Two Siblings With Mild Developmental DelaysArchives of Pediatrics & Adolescent Medicine, 1978
- Nonketotic hyperglycinemia: Report of a case and review of the clinical, chemical, and pathological changesAnnals of Neurology, 1977
- A Familial Spinal Cord DisorderArchives of Neurology, 1972